ORGANIZATION

• Labor Union Calls for Uniform Hike in Drug Prices, Lawmakers Urge Overhaul
  October 29, 2025

• JMA Renews Opposition to Insurance Review for OTC-Like Drugs
  October 24, 2025

• MFN Drug Pricing Already Affecting 4 Firms’ R&D Plans in Japan, EFPIA Chief Flags Fallout
  October 22, 2025

• JPMA Chief Hails Takaichi’s Election as PM, Calls for Stronger Innovation Ecosystem
  October 22, 2025

• Wholesalers to Broaden Lobbying Push to Include Ishin amid Political Shift: Leader
  October 17, 2025

• JPMA Chief Renews Call for Reflecting Inflation and Wage Hikes in Drug Pricing
  October 17, 2025

• Pharma-Cosmetic Union Officially Joins Rengo as Associate Organization
  October 9, 2025

• NPhA Urges Pharmacies to Provide Accurate Info on Acetaminophen Use during Pregnancy
  October 6, 2025

• Japan Patient Group Calls for Dupixent Approval in Ichthyosis
  October 6, 2025

• Think Tanks Urge Unique Value Framework for Regenerative Medicine in 2026 Reform
  October 2, 2025

• JETRO Launches Japan Entry Program for Regenerative Medicine Startups
  October 2, 2025

• Policy Veterans’ Group Calls for Inflation-Linked Drug Pricing in FY2026 Reform
  October 1, 2025

• Generic Use Rate Hits Record 89.2% in April-June: JGA
  September 29, 2025

• Kenporen Proposes Higher Copays for Choosing Costlier Drugs
  September 26, 2025

• Japan Wholesalers’ Profit Margin Improves to 1.11% in FY2024
  September 26, 2025

• JPMA Think Tank Chief Pledges to Back Policy Debates with Evidence
  September 26, 2025

• Japanese Pharma-Cosmetic Union Breaks from UA Zensen, Set to Join Rengo
  September 25, 2025

• JPMA to Overhaul Guideline for Handling Drug Inquiries This Fall: Consultation Chair
  September 25, 2025

• Generic Use Rate at 89.6% in April: Payer
  September 25, 2025

• JPMA Publishes TPP Overview to Bridge Academia and Industry: R&D Chair
  September 22, 2025

ページ

• « 先頭
• ‹ Prev
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• Next ›
• 最終 »